Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy.
Walmsley CS, Jonsson P, Cheng ML, McBride S, Kaeser C, Vargas HA, Laudone V, Taylor BS, Kappagantula R, Baez P, Richards AL, Noronha AM, Perera D, Berger M, Solit DB, Iacobuzio-Donahue CA, Scher HI, Donoghue MTA, Abida W, Schram AM.
Walmsley CS, et al. Among authors: solit db.
NPJ Precis Oncol. 2024 Feb 14;8(1):34. doi: 10.1038/s41698-024-00526-9.
NPJ Precis Oncol. 2024.
PMID: 38355834
Free PMC article.